Clinical Trials Browser

Phase 2 × NETWORK × lenvatinib × Clear all

NCT06880523 2025-12-18

SLIDE-HCC

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT06068153 2024-11-20

AMBER

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung

NCT03005015 2016-12-29

Lenvatinib in Second Line Endometrial Carcinoma

Phase 2 Withdrawn

Endometrial Neoplasms